Loading company…
Proteostasis Therapeutics develops small molecule treatments targeting the body's protein homeostasis network.
Founded in 2006 and based in Massachusetts, US, Proteostasis Therapeutics develops small molecule therapeutics targeting the body's protein homeostasis network. Its products address cystic fibrosis, neurodegenerative diseases and orphan diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in